Full Library
Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure
Resource type
Journal Article
Authors/contributors
- Daoud-Asfour, Haneen (Author)
- Henig, Israel (Author)
- Ghersin, Itai (Author)
- Rakedzon, Stav (Author)
- Stern, Anat (Author)
- Pitashny, Milena (Author)
- Zuckerman, Tsila (Author)
- Bar-Yoseph, Haggai (Author)
Title
Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure
Publication
Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Date
2022-03-01
Volume
28
Issue
3
Pages
168.e1-168.e8
Journal Abbr
Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Accessed
4/2/22, 7:21 AM
ISSN
2666-6367, 2666-6375
Language
English
Library Catalog
Extra
Publisher: Elsevier
PMID: 34954293
Citation
Daoud-Asfour, H., Henig, I., Ghersin, I., Rakedzon, S., Stern, A., Pitashny, M., Zuckerman, T., & Bar-Yoseph, H. (2022). Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure. Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy, 28(3), 168.e1-168.e8. https://doi.org/10.1016/j.jtct.2021.12.012
HEME-ONC AND CELLULAR THERAPIES
Link to this record